An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx

Author： Oesterling J.E.   Moyad M.A.   Wright G.L.   Beck G.R.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.46, Iss.4, 1995-10, pp. : 524-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methodological and clinical comparison of the ACS prostate-specific antigen assay and the tandem-E prostate-specific antigen assay in prostate cancer

By Schambeck C.M.   Schmeller N.   Stieber P.   Jansen H.-M.   Pahl H.   Schneider W.   Fateh-Moghadam A.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 195-199

Elsevier

Access to resources Recommend Favorite

Comparability of serum prostate-specific antigen measurement between the Hybritech Tandem-R and Abbott AxSYM assays - need for an international standard

By Leewansangtong S.   Goktas S.   Lepoff R.   Holthaus K.   Crawford E.D.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 467-469

Elsevier

Access to resources Recommend Favorite

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL

By Okegawa T.   Noda H.   Nutahara K.   Higashihara E.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite

Comparison of four automated prostate-specific antigen assays for detection of recurrence after radical prostatectomy

By Sanders H.   Graham S.D.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 894-897

Elsevier

Access to resources Recommend Favorite

Prognostic value of three molecular forms of prostate-specific antigen ratios in patients with prostate adenocarcinoma

By Okegawa T.   Kato M.   Nutahara K.   Higashihara E.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 936-942

Elsevier

Access to resources Recommend Favorite